conclusions following cabg, the most severity of pain was reported at surgical incision on time t2. pain began to decrease from the third day following the operation. age, sex and bmi along with operation-related factors such as duration of cbp or chest tube drainage may affect the pain pattern following cabg surgery. patients and methods the present study was conducted on 138 patients who unde...

Pharmacological management of persistent aggression in patients with schizophrenia is a difficult clinical dilemma. Clozapine has been shown to be an effective agent in this regard. This study sought to compare the symptomatic response on the Brief Psychiatric Rating Scale (BPRS) between hostile schizophrenic patients and patients without aggression. While dramatic improvements were evident in ...

Schizophrenia patients exhibit deficits in recognition and identification of facial emotional expressions, but it is unclear whether these deficits result from abnormal affective processing or an impaired ability to process complex visual stimuli such as faces. Participants comprised 16 outpatients with schizophrenia and 22 matched healthy control subjects who performed two computerized visual ...

This study examines the factor structure of the Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4) for inpatients with schizophrenia in a psychiatric hospital in southern Taiwan. All the participants (n = 100) filled out the SQLS-R4, Mini Mental Status Examination (MMSE), and Brief Psychiatric Rating Scale (BPRS) under the supervision of one experienced occupational therapist. Using confi...

Quality of life is an important outcome in the treatment of patients with schizophrenia. It has been suggested that patients' quality of life ratings (referred to as subjective quality of life, SQOL) might be too heavily influenced by symptomatology to be a valid independent outcome criterion. There has been only limited evidence on the association of symptom change and changes in SQOL over tim...

Electroconvulsive therapy (ECT) is effective in treatment-resistant depression (TRD). It may act through intracellular process modulation, but its exact mechanism is still unknown. Animal research supports a neurotrophic effect for ECT. We aimed to investigate the association between changes in serum brain-derived neurotrophic factor (sBDNF) levels and clinical improvement following ECT in pati...

The authors report the results of a confirmatory factor analysis of symptoms assessed with the Brief Psychiatric Rating Scale (BPRS) in a sample of 474 patients with schizophrenia, replicated in an independent sample of 327 patients. The most commonly used 5-factor solution for the BPRS fit the data poorly. Exploratory factor analyses performed on the first sample led to the specification of a ...

Background: Electroconvulsive therapy (ECT) has been reported being a safe and effective treatment in schizophrenia. However, there are a limited number of studies assessing continuation ECT utilization in patients with schizophrenia giving partial response to pharmacological treatment. Objective: The aim of this study is to evaluate the effectiveness of continuation ECT in preventing relapse i...